Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Can anti-Müllerian hormone concentrations be used to determine gonadotrophin dose and treatment protocol for ovarian stimulation?

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Meditation and mindfulness reduce perceived stress in women with recurrent pregnancy loss: a randomized controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Stress and depression among women and men who have experienced recurrent pregnancy loss: focusing on both sexes

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Empathetic application of machine learning may address appropriate utilization of ART

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Futures and fears in the freezer: Danish women's experiences with ovarian tissue cryopreservation and transplantation

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. The reproductive microbiome - clinical practice recommendations for fertility specialists

    Research output: Contribution to journalReviewResearchpeer-review

  1. Serum ferritin level is inversely related to number of previous pregnancy losses in women with recurrent pregnancy loss

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Surgery, gonadotropin-releasing hormone agonist downregulation and in vitro fertilisation in women with infertility and endometriomas

    Research output: Contribution to journalJournal articleResearchpeer-review

  • R Fleming
  • F Broekmans
  • C Calhaz-Jorge
  • L Dracea
  • H Alexander
  • Anders Nyboe Andersen
  • C Blockeel
  • J Jenkins
  • B Lunenfeld
  • P Platteau
  • J Smitz
  • D de Ziegler
View graph of relations
The ability to predict the response potential of women to ovarian stimulation may allow the development of individualized ovarian stimulation protocols. This tailored approach to ovarian stimulation could reduce the incidence of ovarian hyperstimulation syndrome in women predicted to have an excessive response to stimulation or could improve pregnancy outcomes in women classed as poor responders. Namely, variation of the type of gonadotrophin-releasing hormone (GnRH) analogue or the form and dosage of gonadotrophin used for stimulation could be adjusted according to an individual's response potential. The serum concentration of anti-Müllerian hormone (AMH) is established as a reliable marker of ovarian reserve, with decreasing concentrations correlated with reduced response potential. This review examines the current evidence evaluating individualized ovarian stimulation protocols using AMH concentration as a predictive marker of ovarian response. The rationale behind why specific treatment protocols based on individual response potential may be more suitable is also discussed. Based on current evidence, it appears that the use of AMH serum concentrations to predict ovarian response and optimize treatment strategies is a promising approach for improving pregnancy outcomes in women undergoing ovarian stimulation. However, prospective randomized controlled trials evaluating this approach are needed before any firm conclusions can be drawn.
Original languageEnglish
JournalReproductive BioMedicine Online
Volume26
Issue number5
Pages (from-to)431-439
Number of pages9
ISSN1472-6483
DOIs
Publication statusPublished - May 2013

    Research areas

  • Anti-Mullerian Hormone, Biological Markers, Dose-Response Relationship, Drug, Female, Gonadotropins, Humans, Infertility, Female, Ovarian Hyperstimulation Syndrome, Ovary, Ovulation Induction, Predictive Value of Tests, Reproducibility of Results

ID: 42461604